Anavex Life Sciences Corp (AVXL)

[nidan7500]

sokol

If Blarcamesine works well with APOE3 patients, Anavex will focus on those APOE3 patients. This too would be highly significant in seeking approval in Asia. APOE3 is the most common among all human populations. Interestingly, its frequency varies throughout the world. Most interestingly its frequency in Asia seems to be the highest - 85%. ! APOE4 is relatively high in Australia, but highest in Central Africa.

Thanks for illustrating some of the unknown-unknowns and complexities of our CNS (systems) . Does this possibly illustrate-(point to) the complexities of this CNS MOA upstream learning process/path we may have inadvertently stepped onto. I think so...but, we have no choice...we must keep moving ...

Like Yogie Berra would say...."when you get to a fork in the road...take it". (or something like that).